{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:08:42Z","timestamp":1760054922099,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.respe.2020.10.008","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T11:45:33Z","timestamp":1607687133000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Profil de d\u00e9livrance des antid\u00e9presseurs chez l\u2019enfant et l\u2019adolescent en Midi-Pyr\u00e9n\u00e9es entre 2015\u00a0et 2017"],"prefix":"10.1016","volume":"69","author":[{"given":"J.","family":"Nguyen-Soenen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Driot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Verges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dupouy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Birebent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.respe.2020.10.008_bib0165","first-page":"881","article-title":"[Antidepressants do prevent suicide, at least pending something better.]","volume":"198","author":"Courtet","year":"2014","journal-title":"Bull Acad Natl Med"},{"year":"2014","series-title":"Haute Autorit\u00e9 de Sant\u00e9 - Manifestations d\u00e9pressives \u00e0 l\u2019adolescence: rep\u00e9rage diagnostic et prise en charge en soins de premier recours","author":"Haute Autorit\u00e9 de Sant\u00e9","key":"10.1016\/j.respe.2020.10.008_bib0170"},{"year":"2008","series-title":"Mise au point sur le bon usage des antid\u00e9presseurs chez l\u2019enfant et l\u2019adolescent","author":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire du m\u00e9dicaments et des produits de sant\u00e9","key":"10.1016\/j.respe.2020.10.008_bib0175"},{"key":"10.1016\/j.respe.2020.10.008_bib0180","first-page":"1","article-title":"Paediatric antidepressants: Benefits and risks","author":"Healy","year":"2018","journal-title":"Int J Risk Saf Med"},{"key":"10.1016\/j.respe.2020.10.008_bib0185","article-title":"Antidepressant-induced activation in children and adolescents: risk, recognition and management","author":"Luft","year":"2018","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1016\/j.respe.2020.10.008_bib0190","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00787-013-0395-9","article-title":"Antidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study","volume":"22","author":"D\u00f6rks","year":"2013","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.respe.2020.10.008_bib0195","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/pds.4289","article-title":"Extent and risks of antidepressant off-label use in children and adolescents in Germany between 2004\u00a0and 2011","volume":"26","author":"Schr\u00f6der","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.respe.2020.10.008_bib0200","article-title":"[Management of child and adolescent depression in primary care: A systematic meta-review]","author":"Driot","year":"2019","journal-title":"L\u2019Encephale"},{"year":"2011","series-title":"\u00c9valuation du plan psychiatrie et sant\u00e9 mentale","author":"HCSP","key":"10.1016\/j.respe.2020.10.008_bib0205"},{"key":"10.1016\/j.respe.2020.10.008_bib0210","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.neurenf.2008.12.007","article-title":"Besoin de soins en sant\u00e9 mentale versus besoin de soins en p\u00e9dopsychiatrie. Approche \u00e9pid\u00e9miologique","volume":"57","author":"Kovess-Masfety","year":"2009","journal-title":"Neuropsychiatr Enfance Adolesc"},{"key":"10.1016\/j.respe.2020.10.008_bib0215","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/JCP.0000000000000891","article-title":"Trends and Patterns of Antidepressant Use in French Children and Adolescents From 2009\u00a0to 2016","volume":"38","author":"Revet","year":"2018","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.respe.2020.10.008_bib0220","first-page":"954","article-title":"The national healthcare system claims databases in France","volume":"26","author":"Bezin","year":"2017","journal-title":"SNIIRAM and EGB: Powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.respe.2020.10.008_bib0225","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: From the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev D\u00c9pid\u00e9miologie Sant\u00e9 Publique"},{"journal-title":"Journal Officiel de la R\u00e9publique Fran\u00e7aise","article-title":"D\u00e9cret n\u030a 2016-1537\u00a0du 16\u00a0novembre 2016\u00a0relatif aux recherches impliquant la personne humaine","year":"2016","key":"10.1016\/j.respe.2020.10.008_bib0230"},{"journal-title":"Journal Officiel de la R\u00e9publique Fran\u00e7aise","article-title":"Arr\u00eat\u00e9 du 11\u00a0juillet 2012\u00a0relatif \u00e0 la mise en \u0153uvre du syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019assurance maladie","year":"2012","key":"10.1016\/j.respe.2020.10.008_bib0235"},{"year":"2017","series-title":"ATC\/DDD Index","author":"Collaborating Center for Drug Statistics W.H.O","key":"10.1016\/j.respe.2020.10.008_bib0240"},{"year":"2009","series-title":"Affections psychiatriques de longue dur\u00e9e. Troubles d\u00e9pressifs r\u00e9currents ou persistants de l\u2019adulte","author":"Haute Autorit\u00e9 de sant\u00e9","key":"10.1016\/j.respe.2020.10.008_bib0245"},{"year":"2013","series-title":"Direction de l\u2019Evaluation M\u00e9dicale Economique et de Sant\u00e9 Publique. Avis de la Comission de la Transparence - clomipramine","author":"HAS","key":"10.1016\/j.respe.2020.10.008_bib0250"},{"year":"2016","series-title":"Direction de l\u2019Evaluation M\u00e9dicale Economique et de Sant\u00e9 Publique. Avis de la Comission de la Transparence - amitriptyline","author":"HAS","key":"10.1016\/j.respe.2020.10.008_bib0255"},{"key":"10.1016\/j.respe.2020.10.008_bib0260","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.arcped.2011.05.016","article-title":"Prise en charge des douleurs neuropathiques chez l\u2019enfant: Recommandations de bonne pratique clinique","volume":"18","author":"Fournier-Charri\u00e8re","year":"2011","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.respe.2020.10.008_bib0265","unstructured":"AFSSAPS. Prise en charge m\u00e9dicamenteuse de la douleur aigu\u00eb et chronique chez l\u2019enfant 2009. https:\/\/www.pediadol.org\/Afssaps-Prise-en-charge.html.(accessed December 6, 2018)."},{"key":"10.1016\/j.respe.2020.10.008_bib0270","unstructured":"Assurance Maladie. Couverture maladie universelle compl\u00e9mentaire (CMU-C) 2018. https:\/\/www.ameli.fr\/l-assurance-maladie\/statistiques-et-publications\/donnees-statistiques\/couverture-maladie-universelle-cmu.php.(accessed February 12, 2019)."},{"key":"10.1016\/j.respe.2020.10.008_bib0275","unstructured":"Insee. Statistiques 2019. https:\/\/www.insee.fr\/fr\/statistiques?debut=0&theme=1&geo=COMPRD-1&idfacette=3.(accessed February 12, 2019)."},{"key":"10.1016\/j.respe.2020.10.008_bib0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1017\/S2045796011000722","article-title":"The relationship between socio-economic status and antidepressant prescription: a longitudinal survey and register study of young adults","volume":"21","author":"von Soest","year":"2012","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.respe.2020.10.008_bib0285","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0031-3955(05)70071-7","article-title":"Drug-drug interactions in pediatric psychopharmacology","volume":"45","author":"Ten Eick","year":"1998","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.respe.2020.10.008_bib0290","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jamapsychiatry.2017.2410","article-title":"Effectiveness and safety of antidepressants for children and adolescents","volume":"74","author":"Merry","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.respe.2020.10.008_bib0295","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1176\/appi.ajp.160.3.438","article-title":"Reviews and overviews concomitant psychotropic medication for youths","volume":"160","author":"Safer","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.respe.2020.10.008_bib0300","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jpeds.2018.05.040","article-title":"Selective serotonin reuptake inhibitors reduce longitudinal growth in risperidone-treated boys","volume":"201","author":"Calarge","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.respe.2020.10.008_bib0305","unstructured":"ameli.fr. La source du DCIR - Wiki SNIIRAM 2015. http:\/\/open-data-assurance-maladie.ameli.fr\/wiki-sniiram\/index.php\/La_source_du_DCIR.(accessed July 15, 2019)."},{"key":"10.1016\/j.respe.2020.10.008_bib0310","unstructured":"Haute Autorit\u00e9 de sant\u00e9. Programme pluriannuel Psychiatrie et sant\u00e9 mentale 2018-2023 2018. https:\/\/www.has-sante.fr\/portail\/jcms\/c_1721760\/fr\/programme-psychiatrie-et-sante-mentale-de-la-has.(accessed February 12, 2019)."},{"key":"10.1016\/j.respe.2020.10.008_bib0315","unstructured":"HAS - Direction de l\u2019Evaluation M\u00e9dicale Economique et de Sant\u00e9 Publique. Avis de la Comission de la Transparence - sertraline 2013. https:\/\/www.has-sante.fr\/portail\/upload\/docs\/evamed\/CT-7400_ZOLOFT_PIC_avis1_CT7400.pdf.(accessed December 6, 2018)."},{"key":"10.1016\/j.respe.2020.10.008_bib0160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.purol.2009.12.007","article-title":"\u00c9nur\u00e9sie nocturne primaire isol\u00e9e: diagnostic et prise en charge. Recommandations par consensus formalis\u00e9 d\u2019experts","volume":"20","author":"Aubert","year":"2010","journal-title":"Prog En Urol"}],"container-title":["Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398762020304958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398762020304958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:42:07Z","timestamp":1759970527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0398762020304958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0398762020304958"],"URL":"https:\/\/doi.org\/10.1016\/j.respe.2020.10.008","relation":{},"ISSN":["0398-7620"],"issn-type":[{"type":"print","value":"0398-7620"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profil de d\u00e9livrance des antid\u00e9presseurs chez l\u2019enfant et l\u2019adolescent en Midi-Pyr\u00e9n\u00e9es entre 2015\u00a0et 2017","name":"articletitle","label":"Article Title"},{"value":"Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.respe.2020.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}